Additional Proxy Soliciting Materials (definitive) (defa14a)
April 20 2017 - 6:36AM
Edgar (US Regulatory)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒ Filed by a Party other than the
Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Pursuant to § 240.14a-12
|
SUNESIS
PHARMACEUTICALS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
1.
|
|
Title of each class of securities to which transaction applies:
|
|
|
2.
|
|
Aggregate number of securities to which transaction applies:
|
|
|
3.
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
0-11
(Set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4.
|
|
Proposed maximum aggregate value of transaction:
|
|
|
5.
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
6.
|
|
Amount Previously Paid:
|
|
|
7.
|
|
Form, Schedule or Registration Statement No.:
|
|
|
8.
|
|
Filing Party:
|
|
|
9.
|
|
Date Filed:
|
|
|
|
|
|
|
|
*** Exercise Your
Right
to Vote ***
|
Important Notice Regarding the Availability of Proxy Materials for the
|
Stockholder Meeting to Be Held on May 31, 2017
|
|
|
|
|
Meeting Information
|
|
|
SUNESIS PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
|
Meeting Type:
Annual Meeting
|
|
|
|
|
For holders as of:
April 04, 2017
|
|
|
|
|
Date:
May 31, 2017
Time:
11:00 AM PDT
|
|
|
|
|
Location:
|
|
395 Oyster Point Boulevard
|
|
|
|
|
|
|
Suite 400
|
|
|
|
|
|
|
South San Francisco, CA 94080
|
|
|
|
|
You are receiving this communication because you hold
shares in the above named company.
|
|
|
SUNESIS PHARMACEUTICALS, INC.
|
|
|
|
|
395 OYSTER POINT BLVD.,
SUITE
400
SOUTH SAN FRANCISCO, CA 94080
|
|
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy
materials online at
www.proxyvote.com
or easily request a paper copy (see reverse side).
|
|
|
|
|
|
|
|
We encourage you to access and review all of the important information contained in the proxy materials before voting.
|
|
|
|
See the reverse
side of this notice to obtain proxy materials and voting instructions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before You Vote
|
|
|
How to Access the Proxy Materials
|
|
|
Proxy Materials Available to VIEW or RECEIVE:
|
|
|
|
|
1. Notice of Meeting, Annual Report on Form
10-K
and Proxy Statement
|
|
|
|
|
How to View Online:
|
|
|
|
|
Have the information that is printed in the box marked by the arrow
(located on the following page) and visit:
www.proxyvote.com
.
|
|
|
|
|
How to Request and Receive a PAPER or
E-MAIL
Copy:
|
|
|
|
|
If you want to receive a paper or
e-mail
copy of these documents, you must request one. There is NO charge for
requesting a copy. Please choose one of the following methods to make your request:
|
|
|
|
|
|
1)
BY INTERNET
:
|
|
www.proxyvote.com
|
|
|
|
|
|
2)
BY TELEPHONE
:
|
|
1-800-579-1639
|
|
|
|
|
|
3)
BY
E-MAIL*
:
|
|
sendmaterial@proxyvote.com
|
|
|
|
|
* If
requesting materials by
e-mail,
please send a blank
e-mail
with the information that is printed in the box marked by the arrow
(located on the following page) in the subject line.
|
|
|
|
|
Requests, instructions and other inquiries sent to this
e-mail
address will NOT be
forwarded to your investment advisor. Please make the request as instructed above on or before May 17, 2017 to facilitate timely delivery.
|
|
|
|
|
How To Vote
|
|
|
Please Choose One of the Following Voting Methods
|
|
|
Vote In Person:
Many stockholder meetings have attendance requirements including, but not limited to, the possession of an
attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
|
|
Vote By Internet:
To vote now by Internet, go to
www.proxyvote.com.
Have the information that is printed in the box marked by the arrow
available and follow the instructions.
|
|
Vote By Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote FOR the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.
|
|
Vote on Directors To elect the two nominees for director named below to hold offices as Class III members of the Board of Directors
|
|
|
|
|
|
Nominees
|
|
|
|
|
|
|
|
|
|
01)
|
|
David C. Stump, M.D.
|
|
|
|
|
|
|
02)
|
|
Daniel N. Swisher, Jr.
|
|
|
|
|
|
The Board of Directors recommends you vote FOR proposals 2, 3, 4 and 5.
|
|
|
2.
|
|
To approve, on an advisory basis, the compensation of our named executive officers.
|
|
|
3.
|
|
To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of Sunesis for the year ending December 31, 2017.
|
|
|
4.
|
|
To approve the stock option exchange program.
|
|
|
5.
|
|
To approve the amendment of the Sunesis 2011 equity Incentive Plan.
|
|
NOTE:
Such other business as may properly come before the meeting or any adjournment thereof.
|
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Apr 2023 to Apr 2024